QuidelOrtho (QDEL) EVP details option and RSU holdings

Rhea-AI Filing Summary

QuidelOrtho Corp executive vice president Bryan Michael Hanson filed an initial ownership report showing existing equity awards rather than new trades. He directly holds multiple incentive and non-qualified stock options on common stock with exercise prices ranging from $27.17 to $179.06, plus several restricted stock unit grants, including one for 36,152 underlying shares, and 900 common shares. Footnotes detail vesting schedules through dates such as July 1, 2028 and January 30, 2029, with each restricted stock unit convertible into one common share.

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Hanson Bryan Michael

(Last) (First) (Middle)

9975 SUMMERS RIDGE ROAD

(Street)

SAN DIEGO CALIFORNIA 92121

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
02/04/2026

3. Issuer Name and Ticker or Trading Symbol
QuidelOrtho Corp [ QDEL ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP Global Port. Mgmt & Mkting

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	900	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Incentive Stock Options	(1)	08/22/2027	Common Stock	188	$92.23	D
Incentive Stock Options	(1)	08/22/2027	Common Stock	282	$92.23	D
Incentive Stock Options	(1)	12/20/2029	Common Stock	1,050	$119.06	D
Incentive Stock Options	(1)	08/21/2030	Common Stock	420	$119.06	D
Incentive Stock Options	(1)	03/18/2032	Common Stock	291	$179.06	D
Incentive Stock Options	(1)	03/18/2032	Common Stock	291	$179.06	D
Non-Qualified Stock Options	(1)	12/20/2029	Common Stock	1,050	$119.06	D
Non-Qualified Stock Options	(1)	08/21/2030	Common Stock	420	$119.06	D
Non-Qualified Stock Options	(2)	04/26/2033	Common Stock	4,377	$88.67	D
Non-Qualified Stock Options	(3)	04/22/2034	Common Stock	10,522	$39.08	D
Non-Qualified Stock Options	(4)	07/01/2035	Common Stock	17,392	$29.79	D
Non-Qualified Stock Options	(5)	01/30/2036	Common Stock	36,150	$27.17	D
Restricted Stock Units	(6)	(6)	Common Stock	1,459	(7)	D
Restricted Stock Units	(8)	(8)	Common Stock	446	(7)	D
Restricted Stock Units	(9)	(9)	Common Stock	7,016	(7)	D
Restricted Stock Units	(4)	(4)	Common Stock	17,392	(7)	D
Restricted Stock Units	(10)	(10)	Common Stock	36,152	(7)	D

Explanation of Responses:

1. Vested in full.

2. 2,918 shares are vested in full; the remaining 1,459 shares will vest on April 26, 2026.

3. 3,507 shares are vested in full; 3,507 shares will vest on April 22, 2026 and 3,508 shares will vest on April 22, 2027.

4. 5,797 shares will vest on July 1, 2026, 5,797 shares will vest on July 1, 2027 and 5,798 shares will vest on July 1, 2028.

5. 36,150 shares will vest in equal installments on January 30, 2027, January 30 ,2028 and January 30, 2029.

6. 1,459 shares will vest on April 26, 2026.

7. Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock.

8. 446 shares will vest on August 15, 2026.

9. 7,016 shares will vest in equal installments on April 22, 2026 and April 22, 2027.

10. 12,050 shares will vest on January 30, 2027; the remaining 24,102 shares will vest in equal installments on January 30, 2028 and January 30, 2029.

Remarks:

This Form 3 is being filed late due to unanticipated delays in receiving the Reporting Person's EDGAR codes

	/s/ Euna Greene, attorney-in-fact for Bryan M. Hanson	03/24/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What does the QuidelOrtho (QDEL) Form 3 filing by Bryan Michael Hanson show?

The Form 3 shows Bryan Michael Hanson’s existing equity stake, including stock options, restricted stock units, and 900 common shares. It is an initial ownership report and does not reflect new purchases or sales of QuidelOrtho stock.

What stock options does Bryan Michael Hanson report holding in QuidelOrtho (QDEL)?

He reports holding multiple incentive and non-qualified stock options on QuidelOrtho common stock, with exercise prices between $27.17 and $179.06. These options have expiration dates extending from 2027 through 2036, as detailed in the filing data.

How many QuidelOrtho (QDEL) restricted stock units does Bryan Michael Hanson report?

He reports several restricted stock unit awards, including grants over 1,459, 446, 7,016, 17,392, and 36,152 underlying shares. Footnotes specify vesting dates such as April 26, 2026 and January 30, 2029, with each unit representing one common share.

Does Bryan Michael Hanson report owning QuidelOrtho (QDEL) common stock directly?

Yes. In addition to options and restricted stock units, he reports direct ownership of 900 shares of QuidelOrtho common stock. This direct holding is listed separately from his derivative and restricted stock unit positions in the Form 3 data.

What do the vesting footnotes in the QuidelOrtho (QDEL) Form 3 indicate?

The footnotes describe when portions of Hanson’s awards vest. For example, 7,016 units vest in equal installments on April 22, 2026 and April 22, 2027, while 36,150 option shares vest in equal installments on January 30, 2027, 2028, and 2029.

Are any of Bryan Michael Hanson’s QuidelOrtho (QDEL) equity awards fully vested?

Yes. One footnote states certain awards are “vested in full,” and others specify partially vested amounts. For instance, 2,918 shares from one grant are vested, with the remaining 1,459 shares scheduled to vest on April 26, 2026, according to the disclosure.